INNOVIVA INC (INVA:NASDAQ)
$20.66 0.04 (0.194%)
Analysed INNOVIVA INC (INVA:NASDAQ) News Sources
Bayer (BAYRY) Moves 17.0% Higher: Will This Strength Last?
26-06-2026
yahoo.com
AbbVie (ABBV) Moves 4.2% Higher: Will This Strength Last?
29-06-2026
yahoo.com
AbbVie (ABBV) Q2 Earnings and Revenues Beat Estimates
31-07-2026
yahoo.com
Innoviva Reports Second Quarter 2026 Financial Results; Highlights Recent Company Progress
05-08-2026
yahoo.com
Innoviva Specialty Therapeutics Announces Distribution and Licensing Agreement with Dr. Reddy’s for XACDURO® in Select International Markets
16-06-2026
yahoo.com
Innoviva Specialty Therapeutics (INVA) Partners With Dr. Reddy’s to Expand XACDURO Access Internationally
23-06-2026
yahoo.com
Is Innoviva (INVA) One of the Best Cheap Small Cap Stocks to Buy Now?
01-07-2026
yahoo.com
Innoviva (INVA) Q2 Earnings and Revenues Top Estimates
06-08-2026
yahoo.com
Innoviva Specialty Therapeutics’ Antimicrobial Therapies, XACDURO®, ZEVTERA® and NUZOLVENCE® Designated Finalists for the 2026 Prix Galien USA Best Pharmaceutical Product Award
11-08-2026
yahoo.com
Innoviva to Participate in Upcoming Investor Conferences
02-09-2026
yahoo.com
What is the current price of INNOVIVA INC (INVA:NASDAQ)?
The current price of INNOVIVA INC (INVA:NASDAQ) is $20.66.
INNOVIVA INC (INVA:NASDAQ) absolute price change since previous trading day?
The absolute price change of INNOVIVA INC (INVA:NASDAQ) since the previous trading day is $0.04.
INNOVIVA INC (INVA:NASDAQ) percentage price change since previous trading day?
The percentage price change of INNOVIVA INC (INVA:NASDAQ) since the previous trading day is 0.194%.
What is the most recent average sentiment score for INNOVIVA INC (INVA:NASDAQ)?
The most recent average sentiment score for INNOVIVA INC (INVA:NASDAQ) is 77 out of 100.
What is the most recent average sentiment for INNOVIVA INC (INVA:NASDAQ)?
The most recent sentiment for INNOVIVA INC (INVA:NASDAQ) is .
SEC-8K** Filing Available For INNOVIVA INC (INVA:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.